ConductScience.org, home

Trial · NCT06784843

Dexmedetomidine Versus Midazolam for Peribulbar Block

NCT06784843, Not applicable, Completed, Suez Canal University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Dexmedetomidine Versus Midazolam for Peribulbar Block. Trials, record NCT06784843. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06784843

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Dexmedetomidine Versus Midazolam for Peribulbar Block
NCT number
NCT06784843
Status
Completed
Phases
Not applicable
Enrollment
50 participants, actual
Lead sponsor
Suez Canal University
Conditions
Cataract
Interventions
Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block, Midazolam as an adjuvant to local anesthesia for peribulbar block
First posted
2025-01-20
Last updated
2025-04-30

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primaryonset of motor blockIntraoperative from the moment of local anesthesia injection until the moment of complete and full globe akinesia up to 1 hourThe period of time that passed after the local anesthetic mixture was injected before the eye globe was completely immobile
Secondaryonset of sensory blockIntraoperative from the moment of local anesthesia injection until the moment of complete insensitivity and absent reflexes of the eye up to 1 hourthe period of time following the local anesthetic mixture injection that resulted in total insensitivity and absent eye reflexes
Secondarylength of the motor blockPeriperative from the moment of complete and full globe akinesia until the moment of return back of eye movement up to 1 hourThe time it takes for the entire eye globe to return to free motion after experiencing akinesia
Secondarylength of the sensory blockPeriperative from the moment of complete areflexia until the moment of return back of sensation and reflexes up to 1 hourThe amount of time before the entire eye globe regains sensation after experiencing insensitivity and areflexia andreflexes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06784843

GET https://conductscience.org/api/trials/v1/NCT06784843/registered